197 related articles for article (PubMed ID: 22872642)
1. Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting.
Bayer H; Essig K; Stanzel S; Frank M; Gildersleeve JC; Berger MR; Voss C
J Biol Chem; 2012 Oct; 287(43):35873-86. PubMed ID: 22872642
[TBL] [Abstract][Full Text] [Related]
2. Riproximin is a recently discovered type II ribosome inactivating protein with potential for treating cancer.
Adwan H; Bayer H; Pervaiz A; Sagini M; Berger MR
Biotechnol Adv; 2014 Nov; 32(6):1077-90. PubMed ID: 24699434
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of riproximin, a new type II ribosome-inactivating protein with antineoplastic activity from Ximenia americana.
Voss C; Eyol E; Frank M; von der Lieth CW; Berger MR
FASEB J; 2006 Jun; 20(8):1194-6. PubMed ID: 16641197
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of riproximin from Ximenia americana fruit kernels.
Bayer H; Ey N; Wattenberg A; Voss C; Berger MR
Protein Expr Purif; 2012 Mar; 82(1):97-105. PubMed ID: 22178181
[TBL] [Abstract][Full Text] [Related]
5. Riproximin modulates multiple signaling cascades leading to cytostatic and apoptotic effects in human breast cancer cells.
Pervaiz A; Zepp M; Adwan H; Berger MR
J Cancer Res Clin Oncol; 2016 Jan; 142(1):135-47. PubMed ID: 26163990
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of mucin-specific lectin from Sambucus sieboldiana with simple sugars, normal mucins and tumor-associated mucins. Comparison with other lectins.
Devine PL; Harada H
Biol Chem Hoppe Seyler; 1991 Oct; 372(10):935-42. PubMed ID: 1663364
[TBL] [Abstract][Full Text] [Related]
7. Multivalent lectin-carbohydrate interactions: Energetics and mechanisms of binding.
Dam TK; Brewer CF
Adv Carbohydr Chem Biochem; 2023; 84():23-48. PubMed ID: 37979978
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of mucin-type O-glycosylation (MTOG) induced by peracetyl N-thioglycolyl-d-galactosamine (Ac
Dwivedi V; Saini P; Tasneem A; Agarwal K; Sampathkumar SG
Biochem Biophys Res Commun; 2018 Nov; 506(1):60-65. PubMed ID: 30336974
[TBL] [Abstract][Full Text] [Related]
9. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
10. Binding studies of alpha-GalNAc-specific lectins to the alpha-GalNAc (Tn-antigen) form of porcine submaxillary mucin and its smaller fragments.
Dam TK; Gerken TA; Cavada BS; Nascimento KS; Moura TR; Brewer CF
J Biol Chem; 2007 Sep; 282(38):28256-63. PubMed ID: 17652089
[TBL] [Abstract][Full Text] [Related]
11. Density variant glycan microarray for evaluating cross-linking of mucin-like glycoconjugates by lectins.
Godula K; Bertozzi CR
J Am Chem Soc; 2012 Sep; 134(38):15732-42. PubMed ID: 22967056
[TBL] [Abstract][Full Text] [Related]
12. Riproximin's activity depends on gene expression and sensitizes PDAC cells to TRAIL.
Adwan H; Murtaja A; Kadhim Al-Taee K; Pervaiz A; Hielscher T; Berger MR
Cancer Biol Ther; 2014 Sep; 15(9):1185-97. PubMed ID: 24918923
[TBL] [Abstract][Full Text] [Related]
13. Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.
Haugstad KE; Hadjialirezaei S; Stokke BT; Brewer CF; Gerken TA; Burchell J; Picco G; Sletmoen M
Glycobiology; 2016 Dec; 26(12):1338-1350. PubMed ID: 27282157
[TBL] [Abstract][Full Text] [Related]
14. Single molecule study of heterotypic interactions between mucins possessing the Tn cancer antigen.
Haugstad KE; Stokke BT; Brewer CF; Gerken TA; Sletmoen M
Glycobiology; 2015 May; 25(5):524-34. PubMed ID: 25527429
[TBL] [Abstract][Full Text] [Related]
15. Chemoenzymatic modular assembly of O-GalNAc glycans for functional glycomics.
Wang S; Chen C; Gadi MR; Saikam V; Liu D; Zhu H; Bollag R; Liu K; Chen X; Wang F; Wang PG; Ling P; Guan W; Li L
Nat Commun; 2021 Jun; 12(1):3573. PubMed ID: 34117223
[TBL] [Abstract][Full Text] [Related]
16. Single-molecule pair studies of the interactions of the alpha-GalNAc (Tn-antigen) form of porcine submaxillary mucin with soybean agglutinin.
Sletmoen M; Dam TK; Gerken TA; Stokke BT; Brewer CF
Biopolymers; 2009 Sep; 91(9):719-28. PubMed ID: 19384982
[TBL] [Abstract][Full Text] [Related]
17. Purification, characterization, and sugar binding specificity of an N-Glycolylneuraminic acid-specific lectin from the mushroom Chlorophyllum molybdites.
Kobayashi Y; Kobayashi K; Umehara K; Dohra H; Murata T; Usui T; Kawagishi H
J Biol Chem; 2004 Dec; 279(51):53048-55. PubMed ID: 15471858
[TBL] [Abstract][Full Text] [Related]
18. An improved lectin-based method for the detection of mucin-type O-glycans in biological samples.
Lee CS; Muthusamy A; Abdul-Rahman PS; Bhavanandan VP; Hashim OH
Analyst; 2013 Jun; 138(12):3522-9. PubMed ID: 23665615
[TBL] [Abstract][Full Text] [Related]
19. Exquisite binding specificity of Sclerotium rolfsii lectin toward TF-related O-linked mucin-type glycans.
Chachadi VB; Inamdar SR; Yu LG; Rhodes JM; Swamy BM
Glycoconj J; 2011 Jan; 28(1):49-56. PubMed ID: 21347715
[TBL] [Abstract][Full Text] [Related]
20. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
